Kite Pharma kitepharma.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to recognize and eradicate tumors. In partnership with the NCI Surgery Branch through a Cooperative Research and Development Agreement (CRADA), Kite is advancing a pipeline of proprietary eACT product candidates, both CAR (chimeric antigen receptor) and TCR (T cell receptor) products, directed to a wide...Show all

Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to recognize and eradicate tumors. In partnership with...Show all

Company (Acquired)

Phone: 650-574-3000

Fax:

2225 Colorado Avenue

Foster City, 94404
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Kite Pharma $85.3M Oct 3, 2017
Bluebird Bio $349.2M Aug 6, 2018
Juno Therapeutics $574.6M Mar 6, 2018
See all 3 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Kite Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors
See all 3 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antigen binding molecules and methods of use thereof Sep 21, 2018 Nov 24, 2020 Patent
Humanized antigen-binding domains and methods of use Apr 24, 2018 Nov 24, 2020 Patent
Bcma binding molecules and methods of use thereof Mar 31, 2017 Jun 23, 2020 Patent
Antigen binding molecules and methods of use thereof Sep 27, 2017 Apr 21, 2020 Patent
Chimeric antigen and t cell receptors and methods of use Mar 31, 2017 Mar 31, 2020 Patent
See all 43 patents